首页 > 最新文献

Annals of Tropical Paediatrics最新文献

英文 中文
Missed opportunities for prevention of tuberculosis in children. 错失预防儿童结核病的机会。
Pub Date : 2011-01-01 DOI: 10.1179/146532811X13142348016691
S M Graham
All children with tuberculosis (TB) represent a missed opportunity for preventive therapy — theoretically. Of course, not all children with TB will have an identifiable source case because, in TB-endemic settings, exposure and infection do occur to varying degrees beyond the known, inner circle of the ‘household’. Nonetheless, risk factors for TB infection are well known and include clinical characteristics of the source case such as degree of sputum smear-positivity along with closeness and duration of contact. Risk factors for developing disease following infection are also recognised and the risk to children is greatest in the youngest and the immunosuppressed. These risk factors provide the logic for the importance given to a contact history in the clinical approach to diagnosis of TB in young children and for the universally recommended contact-screening. Contact screening has two main aims: (1) to identify contacts of any age who are symptomatic and so need further investigation and management for possible TB disease, and (2) contacts who do not have active TB disease but require preventive therapy (or chemoprophylaxis) because they are at high risk of disease following infection. Preventive therapy has proven efficacy in significantly reducing the risk of disease in high-risk groups and is widely recommended for child contacts who are young (0–4 years) or HIVinfected irrespective of age. However, proven effectiveness of preventive therapy in child contacts in the high-burden setting is not established because contact-screening and management are rarely implemented. A study by Du Preez et al. in this issue of Annals of Tropical Paediatrics highlights again the lack of routine implementation of chemoprophylaxis while providing original and important data on its potential effectiveness. The data are considerably strengthened by microbiological confirmation of TB diagnosis in all children included in the study. Of those eligible for preventive therapy, the majority (71%) represented a missed, recorded opportunity with the source case commonly being a parent. The study emphasises the importance of young age as an opportunity and as a consequence of missed opportunity. Most identifiable, missed opportunities were in children aged ,3 years. This is expected, given the increased likelihood of the contact being known to the young child compared with older, more socially mobile children. Further, disseminated disease and death were common in this same group of infants and young children. Timely provision of preventive therapy would have prevented up to 200 of the reported TB cases and a number of TB-related deaths. As acknowledged by the authors, a limitation of the study is the uncertain accuracy of the contact history data collected retrospectively from medical records. However, this might have resulted in under-reporting, thereby providing an underestimate of missed opportunities rather than over-reporting because recording was not prospective or
{"title":"Missed opportunities for prevention of tuberculosis in children.","authors":"S M Graham","doi":"10.1179/146532811X13142348016691","DOIUrl":"https://doi.org/10.1179/146532811X13142348016691","url":null,"abstract":"All children with tuberculosis (TB) represent a missed opportunity for preventive therapy — theoretically. Of course, not all children with TB will have an identifiable source case because, in TB-endemic settings, exposure and infection do occur to varying degrees beyond the known, inner circle of the ‘household’. Nonetheless, risk factors for TB infection are well known and include clinical characteristics of the source case such as degree of sputum smear-positivity along with closeness and duration of contact. Risk factors for developing disease following infection are also recognised and the risk to children is greatest in the youngest and the immunosuppressed. These risk factors provide the logic for the importance given to a contact history in the clinical approach to diagnosis of TB in young children and for the universally recommended contact-screening. Contact screening has two main aims: (1) to identify contacts of any age who are symptomatic and so need further investigation and management for possible TB disease, and (2) contacts who do not have active TB disease but require preventive therapy (or chemoprophylaxis) because they are at high risk of disease following infection. Preventive therapy has proven efficacy in significantly reducing the risk of disease in high-risk groups and is widely recommended for child contacts who are young (0–4 years) or HIVinfected irrespective of age. However, proven effectiveness of preventive therapy in child contacts in the high-burden setting is not established because contact-screening and management are rarely implemented. A study by Du Preez et al. in this issue of Annals of Tropical Paediatrics highlights again the lack of routine implementation of chemoprophylaxis while providing original and important data on its potential effectiveness. The data are considerably strengthened by microbiological confirmation of TB diagnosis in all children included in the study. Of those eligible for preventive therapy, the majority (71%) represented a missed, recorded opportunity with the source case commonly being a parent. The study emphasises the importance of young age as an opportunity and as a consequence of missed opportunity. Most identifiable, missed opportunities were in children aged ,3 years. This is expected, given the increased likelihood of the contact being known to the young child compared with older, more socially mobile children. Further, disseminated disease and death were common in this same group of infants and young children. Timely provision of preventive therapy would have prevented up to 200 of the reported TB cases and a number of TB-related deaths. As acknowledged by the authors, a limitation of the study is the uncertain accuracy of the contact history data collected retrospectively from medical records. However, this might have resulted in under-reporting, thereby providing an underestimate of missed opportunities rather than over-reporting because recording was not prospective or","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 4","pages":"297-9"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/146532811X13142348016691","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40117446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Perinatal tuberculosis: four cases and use of broncho-alveolar lavage. 围产期肺结核4例及支气管肺泡灌洗术的应用。
Pub Date : 2011-01-01 DOI: 10.1179/146532811X12925735813841
A Parakh, R Saxena, R Thapa, G R Sethi, S Jain

Despite the high prevalence of tuberculosis in adults and children, congenital and perinatal forms of tuberculosis are rare. Four patients with perinatal tuberculosis are described. Diagnosis was made by demonstration of acid-fast bacilli (AFB) on broncho-alveolar lavage (BAL) specimens (two cases), gastric aspirate smear (one case) and lymph node fine-needle aspirate (one case). All of the above specimens were subsequently positive on culture. Two infants died of progressive pulmonary failure, and one of the mothers died, despite the institution of anti-tuberculous therapy. BAL specimen examination for AFB is useful in the diagnosis of perinatal tuberculosis, especially in infants with smear-negative gastric aspirate.

尽管结核病在成人和儿童中发病率很高,但先天性和围产期形式的结核病很少见。本文描述了4例围产期肺结核患者。通过支气管肺泡灌洗(BAL)标本(2例)、胃吸痰涂片(1例)和淋巴结细针吸痰(1例)显示抗酸杆菌(AFB)进行诊断。以上所有标本随后均为培养阳性。尽管进行了抗结核治疗,但两名婴儿死于进行性肺衰竭,其中一名母亲死亡。BAL标本检查AFB是有用的诊断围产期结核,特别是在婴儿涂片阴性胃抽吸。
{"title":"Perinatal tuberculosis: four cases and use of broncho-alveolar lavage.","authors":"A Parakh,&nbsp;R Saxena,&nbsp;R Thapa,&nbsp;G R Sethi,&nbsp;S Jain","doi":"10.1179/146532811X12925735813841","DOIUrl":"https://doi.org/10.1179/146532811X12925735813841","url":null,"abstract":"<p><p>Despite the high prevalence of tuberculosis in adults and children, congenital and perinatal forms of tuberculosis are rare. Four patients with perinatal tuberculosis are described. Diagnosis was made by demonstration of acid-fast bacilli (AFB) on broncho-alveolar lavage (BAL) specimens (two cases), gastric aspirate smear (one case) and lymph node fine-needle aspirate (one case). All of the above specimens were subsequently positive on culture. Two infants died of progressive pulmonary failure, and one of the mothers died, despite the institution of anti-tuberculous therapy. BAL specimen examination for AFB is useful in the diagnosis of perinatal tuberculosis, especially in infants with smear-negative gastric aspirate.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"75-80"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/146532811X12925735813841","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29621854","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 18
Auto-immune haemolytic anaemia concurrent with Plasmodium vivax infection: a case report. 自身免疫性溶血性贫血并发间日疟原虫感染1例报告。
Pub Date : 2011-01-01 DOI: 10.1179/1465328110Y.0000000003
R Sitcharungsi, U Anurathapan, N Sirachainan, P Chanthavanich

A 7-month-old Myanmar boy was admitted with a 3-day history of fever. He was markedly pale and his temperature was 38·2°C. Peripheral blood smear demonstrated Plasmodium vivax infection with spherocytosis and auto-agglutination of red blood cells. Haematocrit was 16% and reticulocyte count 14·9%. Direct and indirect antiglobulin tests were positive. Antibody analysis was positive for auto-antigen I. P. vivax malaria with auto-immune haemolytic anaemia (AIHA) was diagnosed. He was treated with chloroquine and primaquine for the P. vivax infection, and oral prednisolone for the AIHA. Because of the clinical symptoms of anaemia and mild dyspnoea, blood with the least incompatible red blood cells was transfused. The clinical symptoms and signs improved. At follow-up 3 and 7 weeks after treatment, his haematocrit, reticulocyte count and peripheral blood smear results were within normal limits. Prednisolone was then tapered and stopped. The patient has since been well with no detectable recurrence of AIHA.

一名7个月大的缅甸男婴因3天发热病史入院。患者面色明显苍白,体温38.2℃。外周血涂片显示间日疟原虫感染,红细胞增多,红细胞自身凝集。红细胞压积16%,网织红细胞计数14.9%。直接和间接抗球蛋白试验均为阳性。抗体分析自身抗原ⅰ阳性,诊断为间日疟原虫合并自身免疫性溶血性贫血(AIHA)。间日疟原虫感染给予氯喹和伯氨喹治疗,AIHA给予口服强的松龙治疗。因临床表现为贫血和轻度呼吸困难,输注红细胞相容性最小的血液。临床症状和体征得到改善。治疗后3周和7周随访,患者红细胞压积、网织红细胞计数和外周血涂片结果均在正常范围内。然后逐渐减少并停止使用强的松龙。自那以后,患者一直很好,没有发现AIHA复发。
{"title":"Auto-immune haemolytic anaemia concurrent with Plasmodium vivax infection: a case report.","authors":"R Sitcharungsi,&nbsp;U Anurathapan,&nbsp;N Sirachainan,&nbsp;P Chanthavanich","doi":"10.1179/1465328110Y.0000000003","DOIUrl":"https://doi.org/10.1179/1465328110Y.0000000003","url":null,"abstract":"<p><p>A 7-month-old Myanmar boy was admitted with a 3-day history of fever. He was markedly pale and his temperature was 38·2°C. Peripheral blood smear demonstrated Plasmodium vivax infection with spherocytosis and auto-agglutination of red blood cells. Haematocrit was 16% and reticulocyte count 14·9%. Direct and indirect antiglobulin tests were positive. Antibody analysis was positive for auto-antigen I. P. vivax malaria with auto-immune haemolytic anaemia (AIHA) was diagnosed. He was treated with chloroquine and primaquine for the P. vivax infection, and oral prednisolone for the AIHA. Because of the clinical symptoms of anaemia and mild dyspnoea, blood with the least incompatible red blood cells was transfused. The clinical symptoms and signs improved. At follow-up 3 and 7 weeks after treatment, his haematocrit, reticulocyte count and peripheral blood smear results were within normal limits. Prednisolone was then tapered and stopped. The patient has since been well with no detectable recurrence of AIHA.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"87-91"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328110Y.0000000003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29621856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy. 一名篮球运动员男孩感染甲型流感(H3N2)后劳力性横纹肌溶解。
Pub Date : 2011-01-01 DOI: 10.1179/1465328110Y.0000000005
E Sevketoglu, B Kural, A E Beskardes, S Hatipoglu

A 14-year-old professional basketball player developed symptoms of influenza which was subsequently confirmed to be caused by influenza A (H3N2). He was given a 5-day course of oseltamivir. Two days after completing the course, he resumed basketball and developed rhabdomyolysis associated with acute renal failure and disseminated intravascular coagulation. This appears to be the first report of exercise-induced rhabdomyolysis associated with influenza A (H3N2).

一名14岁职业篮球运动员出现流感症状,其后证实是由甲型流感(H3N2)引致。给予5天疗程的奥司他韦。课程结束两天后,他重新开始打篮球,并出现横纹肌溶解,伴有急性肾功能衰竭和弥散性血管内凝血。这似乎是与甲型流感(H3N2)相关的运动诱导横纹肌溶解的第一份报告。
{"title":"Exertional rhabdomyolysis after influenza A (H3N2) infection in a basketball player boy.","authors":"E Sevketoglu,&nbsp;B Kural,&nbsp;A E Beskardes,&nbsp;S Hatipoglu","doi":"10.1179/1465328110Y.0000000005","DOIUrl":"https://doi.org/10.1179/1465328110Y.0000000005","url":null,"abstract":"<p><p>A 14-year-old professional basketball player developed symptoms of influenza which was subsequently confirmed to be caused by influenza A (H3N2). He was given a 5-day course of oseltamivir. Two days after completing the course, he resumed basketball and developed rhabdomyolysis associated with acute renal failure and disseminated intravascular coagulation. This appears to be the first report of exercise-induced rhabdomyolysis associated with influenza A (H3N2).</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"93-6"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328110Y.0000000005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29621857","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Prevalence of rheumatic heart disease among school-children in Aden, Yemen. 也门亚丁学龄儿童风湿性心脏病患病率。
Pub Date : 2011-01-01 DOI: 10.1179/1465328110Y.0000000007
I A Ba-Saddik, A A Munibari, M S Al-Naqeeb, C M Parry, C A Hart, L E Cuevas, J B S Coulter

Background: Rheumatic heart disease (RHD) is an important contributor to cardiovascular disease in children and adults in Yemen. This is the first report to determine the prevalence of RHD among school-children in the city of Aden.

Methods: A cross-sectional case-finding survey of RHD was conducted in 6000 school-children aged 5-16 years. Echocardiography was undertaken in those with clinical signs of organic heart disease.

Results: The prevalence of RHD was 36·5/1000 school-children, which is one of the highest reported among school echocardiography surveys in the world. RHD was more common in 10-16-year-old students. RHD was diagnosed in more than one member of the families of 53 (24·2%) of the children. Mitral regurgitation (MR) was detected in 49·8%, 26·6% had MR with mitral valve prolapse and 17·8% had combined MR and aortic regurgitation. Fifty-eight children were diagnosed with congenital heart disease (CHD), representing a prevalence of 9·7/1000. The main types of CHD were mitral valve prolapse, patent ductus arteriosus, atrial septal defect, pulmonary stenosis and aortic stenosis. Congenital mitral valve prolapse found in 36 children was three times more common in males than females. Children with RHD were more likely to be from low-income families with poor housing and greater overcrowding (49·3%, 39·3% and 64·8%) than children with CHD (44·8%, 32·8% and 48·3%, respectively).

Conclusions: The high prevalence of RHD is a major public health problem in Yemen. Urgent screening surveys and an RHD prophylactic programme of appropriate management of group A β-haemolytic streptococcal pharyngotonsilitis are required.

背景:风湿性心脏病(RHD)是也门儿童和成人心血管疾病的重要诱因。这是确定亚丁市学龄儿童中RHD患病率的第一份报告。方法:对6000名5 ~ 16岁学龄儿童进行RHD横断面调查。对有器质性心脏病临床症状的患者进行超声心动图检查。结果:RHD患病率为36.5 /1000,是世界上超声心动图调查中报告率最高的学校之一。RHD在10-16岁的学生中更为常见。53例(24.2%)患儿不止一名家庭成员被诊断为RHD。二尖瓣反流(MR) 49.8%, MR合并二尖瓣脱垂26.6%,MR合并主动脉反流17.8%。58名儿童被诊断为先天性心脏病(CHD),患病率为9.7 /1000。冠心病的主要类型为二尖瓣脱垂、动脉导管未闭、房间隔缺损、肺动脉狭窄和主动脉狭窄。在36例儿童中发现先天性二尖瓣脱垂,男性比女性多三倍。与冠心病儿童(分别为44.8%、32.8%和48.3%)相比,RHD儿童更可能来自住房条件差和过度拥挤的低收入家庭(分别为49.3%、39.3%和64.8%)。结论:RHD的高患病率是也门的一个主要公共卫生问题。需要紧急筛查调查和RHD预防计划,以适当管理A组β溶血性链球菌咽喉炎。
{"title":"Prevalence of rheumatic heart disease among school-children in Aden, Yemen.","authors":"I A Ba-Saddik,&nbsp;A A Munibari,&nbsp;M S Al-Naqeeb,&nbsp;C M Parry,&nbsp;C A Hart,&nbsp;L E Cuevas,&nbsp;J B S Coulter","doi":"10.1179/1465328110Y.0000000007","DOIUrl":"https://doi.org/10.1179/1465328110Y.0000000007","url":null,"abstract":"<p><strong>Background: </strong>Rheumatic heart disease (RHD) is an important contributor to cardiovascular disease in children and adults in Yemen. This is the first report to determine the prevalence of RHD among school-children in the city of Aden.</p><p><strong>Methods: </strong>A cross-sectional case-finding survey of RHD was conducted in 6000 school-children aged 5-16 years. Echocardiography was undertaken in those with clinical signs of organic heart disease.</p><p><strong>Results: </strong>The prevalence of RHD was 36·5/1000 school-children, which is one of the highest reported among school echocardiography surveys in the world. RHD was more common in 10-16-year-old students. RHD was diagnosed in more than one member of the families of 53 (24·2%) of the children. Mitral regurgitation (MR) was detected in 49·8%, 26·6% had MR with mitral valve prolapse and 17·8% had combined MR and aortic regurgitation. Fifty-eight children were diagnosed with congenital heart disease (CHD), representing a prevalence of 9·7/1000. The main types of CHD were mitral valve prolapse, patent ductus arteriosus, atrial septal defect, pulmonary stenosis and aortic stenosis. Congenital mitral valve prolapse found in 36 children was three times more common in males than females. Children with RHD were more likely to be from low-income families with poor housing and greater overcrowding (49·3%, 39·3% and 64·8%) than children with CHD (44·8%, 32·8% and 48·3%, respectively).</p><p><strong>Conclusions: </strong>The high prevalence of RHD is a major public health problem in Yemen. Urgent screening surveys and an RHD prophylactic programme of appropriate management of group A β-haemolytic streptococcal pharyngotonsilitis are required.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"37-46"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328110Y.0000000007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29622402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 25
The role of Helicobacter pylori infection in gastro-oesophageal reflux in Iranian children. 幽门螺杆菌感染在伊朗儿童胃食管反流中的作用。
Pub Date : 2011-01-01 DOI: 10.1179/1465328110Y.0000000004
A Abdollahi, A Morteza, O Khalilzadeh, A Zandieh, M Asgarshirazi

Background: The relationship between Helicobacter pylori and gastro-oesophageal reflux disease (GORD) in children is controversial.

Aim: To determine the role of H. pylori infection and GORD in children living in a region which is endemic for H. pylori infection.

Methods: A cross-sectional study was undertaken in 263 children aged 3-18 years, all of whom had symptoms of GORD and underwent upper gastro-intestinal endoscopy. H. pylori status was determined by conventional rapid urease test and Giemsa staining of antral and cardiac biopsies. Biopsies of the oesophagus and gastric mucosa were obtained from the lower oesophagus, the antrum and cardia according to standard protocol.

Results: Of the 263 patients, 81 (31·5%) had GORD and 162 (61·5%) had gastritis. There were 59 H. pylori-infected patients (22·4%) and 204 were uninfected. H. pylori infection was detected in 52 (88·1%) of the antral and 10 (1·9%) of the cardiac biopsies. Three (5·1%) of the biopsies revealed infection of both antrum and cardia and in seven (11·8%) only the cardia was infected. The prevalence of H. pylori infection among patients with GORD (13/83, 15%) was significantly lower than in those without GORD (46/180, 26%) (OR 0·54, CI 0·27-0·93, p<0·05). The prevalence of H. pylori infection among those with gastritis (48/162, 30%) was significantly higher than in those without gastritis (11/101, 10·8%) (OR 3·44, CI 1·69-7·015, p<0·001).

Conclusion: H. pylori infection might protect against GORD.

背景:幽门螺杆菌与儿童胃食管反流病(GORD)的关系尚存争议。目的:探讨幽门螺杆菌感染和GORD在幽门螺杆菌感染流行地区儿童中的作用。方法:对263名3-18岁的儿童进行横断面研究,所有儿童均有GORD症状并行上消化道内窥镜检查。通过常规快速脲酶试验和胃窦和心脏活检的吉姆萨染色来确定幽门螺杆菌的状态。根据标准方案,从食管下段、上颌窦和贲门处进行食管和胃粘膜活检。结果:263例患者中,GORD 81例(31.5%),胃炎162例(61.5%)。幽门螺杆菌感染59例(22.4%),未感染204例。52例(88.1%)胃窦和10例(1.9%)心脏活检检出幽门螺杆菌感染。3例(5.1%)活检同时发现上腔和贲门感染,7例(11.8%)活检仅发现贲门感染。GORD患者幽门螺杆菌感染率(13/ 83,15%)明显低于无GORD患者(46/ 180,26%)(OR 0.54, CI 0.27 ~ 0.93, p)。结论:幽门螺杆菌感染可预防GORD。
{"title":"The role of Helicobacter pylori infection in gastro-oesophageal reflux in Iranian children.","authors":"A Abdollahi,&nbsp;A Morteza,&nbsp;O Khalilzadeh,&nbsp;A Zandieh,&nbsp;M Asgarshirazi","doi":"10.1179/1465328110Y.0000000004","DOIUrl":"https://doi.org/10.1179/1465328110Y.0000000004","url":null,"abstract":"<p><strong>Background: </strong>The relationship between Helicobacter pylori and gastro-oesophageal reflux disease (GORD) in children is controversial.</p><p><strong>Aim: </strong>To determine the role of H. pylori infection and GORD in children living in a region which is endemic for H. pylori infection.</p><p><strong>Methods: </strong>A cross-sectional study was undertaken in 263 children aged 3-18 years, all of whom had symptoms of GORD and underwent upper gastro-intestinal endoscopy. H. pylori status was determined by conventional rapid urease test and Giemsa staining of antral and cardiac biopsies. Biopsies of the oesophagus and gastric mucosa were obtained from the lower oesophagus, the antrum and cardia according to standard protocol.</p><p><strong>Results: </strong>Of the 263 patients, 81 (31·5%) had GORD and 162 (61·5%) had gastritis. There were 59 H. pylori-infected patients (22·4%) and 204 were uninfected. H. pylori infection was detected in 52 (88·1%) of the antral and 10 (1·9%) of the cardiac biopsies. Three (5·1%) of the biopsies revealed infection of both antrum and cardia and in seven (11·8%) only the cardia was infected. The prevalence of H. pylori infection among patients with GORD (13/83, 15%) was significantly lower than in those without GORD (46/180, 26%) (OR 0·54, CI 0·27-0·93, p<0·05). The prevalence of H. pylori infection among those with gastritis (48/162, 30%) was significantly higher than in those without gastritis (11/101, 10·8%) (OR 3·44, CI 1·69-7·015, p<0·001).</p><p><strong>Conclusion: </strong>H. pylori infection might protect against GORD.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"53-7"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328110Y.0000000004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29622404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
Steroid-unresponsive hypereosinophilic syndrome. 类固醇无反应性嗜酸性粒细胞增多综合征。
Pub Date : 2011-01-01 DOI: 10.1179/1465328111Y.0000000027
A Srinivasan, R Lavanya, J Sankar

Hypereosinophilic syndrome in children is rare and is characterised by sustained over-production of eosinophils. An 11-year-old boy was diagnosed with hypereosinophilic syndrome as per standard criteria. He was treated initially with intravenous methylprednisolone, followed by oral prednisolone, to which he showed a limited response. The highest absolute eosinophil count was 27.0×10(9)/L. He was commenced on imatinib mesylate but, because of no response, he was switched to hydroxyurea combined with low-dose prednisolone to which he showed improvement with decreasing levels of eosinophils.

儿童嗜酸性粒细胞过多综合征是罕见的,其特征是嗜酸性粒细胞持续过量产生。一个11岁的男孩被诊断为高嗜酸性粒细胞综合征按照标准标准。他最初接受静脉注射甲基强的松龙治疗,随后口服强的松龙,对其反应有限。嗜酸性粒细胞绝对计数最高为27.0×10(9)/L。他开始使用甲磺酸伊马替尼,但由于无反应,他改用羟基脲联合低剂量强的松龙治疗,他的嗜酸性粒细胞水平下降,病情有所改善。
{"title":"Steroid-unresponsive hypereosinophilic syndrome.","authors":"A Srinivasan,&nbsp;R Lavanya,&nbsp;J Sankar","doi":"10.1179/1465328111Y.0000000027","DOIUrl":"https://doi.org/10.1179/1465328111Y.0000000027","url":null,"abstract":"<p><p>Hypereosinophilic syndrome in children is rare and is characterised by sustained over-production of eosinophils. An 11-year-old boy was diagnosed with hypereosinophilic syndrome as per standard criteria. He was treated initially with intravenous methylprednisolone, followed by oral prednisolone, to which he showed a limited response. The highest absolute eosinophil count was 27.0×10(9)/L. He was commenced on imatinib mesylate but, because of no response, he was switched to hydroxyurea combined with low-dose prednisolone to which he showed improvement with decreasing levels of eosinophils.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 3","pages":"273-7"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328111Y.0000000027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30025429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Long-term immunity after hepatitis B vaccination. 乙肝疫苗接种后的长期免疫。
Pub Date : 2011-01-01 DOI: 10.1179/1465328111Y.0000000026
Rashmi Ranjan Das
I read with interest the article by Metodi et al. In a cross-sectional study, the authors found that more than two-thirds of children under 5 years age who had received DPTHB at 4, 8 and 12 weeks of age had protective anti-HBs levels. On this basis, they suggested changes in the hepatitis B immunisation schedule. A few points require comment. The authors found a lower rate of seroprotection in vaccinated children than in those reported from The Gambia and Turkey. They postulated that the variation might be owing to differences in immunisation schedules, with the birth dose being included in both of the latter studies which included younger children than in their study. However, this is not necessarily true if we consider some recent studies. One half of the children who received a birth dose of hepatitis B vaccine did not have evidence of immune memory as measured by development of anamnestic responses to the booster dose 15 years after vaccination. In another study, 5 years after immunisation with a hexavalent vaccine at 3, 5 and 11 months of age, immunological memory was found to have persisted, suggesting that booster doses are not needed. So neither the sero-protection nor the duration of immunity depends upon the schedule administering a birth dose of vaccine. Antibody persistence and duration of protection against infection are directly proportional to the peak antibody concentration after primary immunisation. Although most children with low peak concentrations lose their antibodies within a few years, they are not at risk of hepatitis as long as they have immunological memory for HBsAg. Memory persists beyond the time at which antibodies are present and protects against disease. The authors’ suggestion of a change in the HB immunisation schedule including a dose immediately after birth to improve immunity is also not supported, as found by our study. In a randomised trial comparing two hepatitis B vaccination schedules (0, 6 and 14 weeks and 6, 10 and 14 weeks), we found that 97.3% of infants in the former group were sero-protected with a geometric mean anti-HBs titre (GMT) of 113.78 mIU/ml vs 94.6% in the latter group (GMT 107.04 mIU/ml) (p50.8). Many other studies which include the birth dose of vaccine have reported similar results, although they have used different schedules. The authors also state that immunological response to the HBV vaccine increases with increasing intervals between the first and third doses, but it is the interval between the second and third doses of vaccine which is associated with improved immunity. Usually, the first two doses are sufficient to initiate the production of antibodies against HBsAg, thereby priming the immune system for a secondary response. The third dose stimulates this secondary response, resulting in a further accelerated response and higher antibody titre than after the first two doses. This is the basis for the conventional 0, 1, 6 months schedule. Finally, the authors’ description of red
{"title":"Long-term immunity after hepatitis B vaccination.","authors":"Rashmi Ranjan Das","doi":"10.1179/1465328111Y.0000000026","DOIUrl":"https://doi.org/10.1179/1465328111Y.0000000026","url":null,"abstract":"I read with interest the article by Metodi et al. In a cross-sectional study, the authors found that more than two-thirds of children under 5 years age who had received DPTHB at 4, 8 and 12 weeks of age had protective anti-HBs levels. On this basis, they suggested changes in the hepatitis B immunisation schedule. A few points require comment. The authors found a lower rate of seroprotection in vaccinated children than in those reported from The Gambia and Turkey. They postulated that the variation might be owing to differences in immunisation schedules, with the birth dose being included in both of the latter studies which included younger children than in their study. However, this is not necessarily true if we consider some recent studies. One half of the children who received a birth dose of hepatitis B vaccine did not have evidence of immune memory as measured by development of anamnestic responses to the booster dose 15 years after vaccination. In another study, 5 years after immunisation with a hexavalent vaccine at 3, 5 and 11 months of age, immunological memory was found to have persisted, suggesting that booster doses are not needed. So neither the sero-protection nor the duration of immunity depends upon the schedule administering a birth dose of vaccine. Antibody persistence and duration of protection against infection are directly proportional to the peak antibody concentration after primary immunisation. Although most children with low peak concentrations lose their antibodies within a few years, they are not at risk of hepatitis as long as they have immunological memory for HBsAg. Memory persists beyond the time at which antibodies are present and protects against disease. The authors’ suggestion of a change in the HB immunisation schedule including a dose immediately after birth to improve immunity is also not supported, as found by our study. In a randomised trial comparing two hepatitis B vaccination schedules (0, 6 and 14 weeks and 6, 10 and 14 weeks), we found that 97.3% of infants in the former group were sero-protected with a geometric mean anti-HBs titre (GMT) of 113.78 mIU/ml vs 94.6% in the latter group (GMT 107.04 mIU/ml) (p50.8). Many other studies which include the birth dose of vaccine have reported similar results, although they have used different schedules. The authors also state that immunological response to the HBV vaccine increases with increasing intervals between the first and third doses, but it is the interval between the second and third doses of vaccine which is associated with improved immunity. Usually, the first two doses are sufficient to initiate the production of antibodies against HBsAg, thereby priming the immune system for a secondary response. The third dose stimulates this secondary response, resulting in a further accelerated response and higher antibody titre than after the first two doses. This is the basis for the conventional 0, 1, 6 months schedule. Finally, the authors’ description of red","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 3","pages":"279-80"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328111Y.0000000026","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"30025430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship of household food insecurity to anaemia in children aged 6-59 months among families in rural Indonesia. 印度尼西亚农村家庭中6-59个月儿童贫血与家庭粮食不安全的关系
Pub Date : 2011-01-01 DOI: 10.1179/1465328111Y.0000000038
A A Campbell, N Akhter, K Sun, S De Pee, K Kraemer, R Moench-Pfanner, J H Rah, J Badham, M W Bloem, R D Semba

Background: Anaemia is a significant global public health problem in developing countries with adverse health effects on young children. Household food insecurity, which reflects a household's access, availability and utilisation of food, has not been well characterised in relation to anaemia in children.

Objective: To examine the relationship of household food insecurity with anaemia (Hb <11 g/dl) in children.

Methods: In a cross-sectional study of 4940 rural households participating in the Indonesian Nutrition Surveillance System, household food insecurity was measured using a modified 9-item food security questionnaire and related to anaemia in children aged 6-59 months.

Results: The proportion of households with an anaemic child was 56·6%. In households with and without anaemic children, the mean (SD) food insecurity score was 1·82 (1·72) vs 1·55 (1·54) (p<0·0001), respectively. In a multivariate logistic regression model, food insecurity score was related to anaemia in children (odds ratio 0·77, 95% confidence interval 0·63-0·95, p=0·01) when the highest quintile of food insecurity score was compared with the lowest quintile, adjusting for potential confounders.

Conclusion: A higher household food insecurity score is associated with greater prevalence of anaemia in children in rural families in Indonesia.

背景:贫血是发展中国家一个重大的全球公共卫生问题,对幼儿健康有不利影响。家庭粮食不安全反映了一个家庭对粮食的获取、供应和利用情况,但在儿童贫血方面还没有得到很好的描述。目的:研究家庭粮食不安全与贫血之间的关系(Hb方法:对参加印度尼西亚营养监测系统的4940个农村家庭进行了横断面研究,使用修改的9项食品安全问卷对家庭粮食不安全进行了测量,并与6-59个月大的儿童贫血有关。结果:有儿童贫血的家庭占比为56.6%。在有和没有贫血儿童的家庭中,平均(SD)粮食不安全评分为1.82(1.72)比1.55 (1.54)(p结论:印度尼西亚农村家庭粮食不安全评分越高,儿童贫血患病率越高。
{"title":"Relationship of household food insecurity to anaemia in children aged 6-59 months among families in rural Indonesia.","authors":"A A Campbell,&nbsp;N Akhter,&nbsp;K Sun,&nbsp;S De Pee,&nbsp;K Kraemer,&nbsp;R Moench-Pfanner,&nbsp;J H Rah,&nbsp;J Badham,&nbsp;M W Bloem,&nbsp;R D Semba","doi":"10.1179/1465328111Y.0000000038","DOIUrl":"https://doi.org/10.1179/1465328111Y.0000000038","url":null,"abstract":"<p><strong>Background: </strong>Anaemia is a significant global public health problem in developing countries with adverse health effects on young children. Household food insecurity, which reflects a household's access, availability and utilisation of food, has not been well characterised in relation to anaemia in children.</p><p><strong>Objective: </strong>To examine the relationship of household food insecurity with anaemia (Hb <11 g/dl) in children.</p><p><strong>Methods: </strong>In a cross-sectional study of 4940 rural households participating in the Indonesian Nutrition Surveillance System, household food insecurity was measured using a modified 9-item food security questionnaire and related to anaemia in children aged 6-59 months.</p><p><strong>Results: </strong>The proportion of households with an anaemic child was 56·6%. In households with and without anaemic children, the mean (SD) food insecurity score was 1·82 (1·72) vs 1·55 (1·54) (p<0·0001), respectively. In a multivariate logistic regression model, food insecurity score was related to anaemia in children (odds ratio 0·77, 95% confidence interval 0·63-0·95, p=0·01) when the highest quintile of food insecurity score was compared with the lowest quintile, adjusting for potential confounders.</p><p><strong>Conclusion: </strong>A higher household food insecurity score is associated with greater prevalence of anaemia in children in rural families in Indonesia.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 4","pages":"321-30"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328111Y.0000000038","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40117366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major. 去铁精素在印度重度β-地中海贫血患儿多次输血中的安全性和有效性。
Pub Date : 2011-01-01 DOI: 10.1179/1465328110Y.0000000002
J Chandra, H Chaudhary, H Pemde, V Singh, A K Dutta

Background: Iron chelation is an important component of management of transfusion-dependent patients with thalassaemia major. Deferasirox is a relatively new oral iron chelator and experience of its use in children is limited.

Aim: To report experience with deferasirox in north Indian children with β-thalassaemia major.

Methods: This prospective study included 40 patients with transfusion-dependent β-thalassaemia major. The patients were receiving deferiprone alone (37 patients) or deferiprone and desferrioxamine combination (three patients) before commencing deferasirox. Patients were clinically monitored every month. Information on side-effects including gastro-intestinal symptoms, skin rash or discoloration, jaundice and complaints regarding vision and hearing were obtained from patient records. Laboratory investigations included complete blood count and renal and liver function tests estimated at baseline and then every month. Serum ferritin level was estimated at baseline and then every 3 months. The initial dose of deferasirox was 20 mg/kg/body weight and was increased to 25 mg/kg if serum ferritin remained unchanged or increased 3 months after deferasirox therapy.

Results: Therapy with deferasirox in 40 children was well tolerated. Gastro-intestinal symptoms were the most common side-effects. Nausea, vomiting and abdominal pain were observed in 25%, 20% and 15% patients, respectively. Skin rashes were seen in 5% cases. We observed greyish-brown pigmentation of the skin in four (10%) children which has not been described before. A non-progressive rise in serum creatinine was observed in 16 (40%) patients. In the majority, however, serum creatinine remained within the normal range. Leucopenia, neutropenia and thrombocytopenia were not observed. None of the side-effects necessitated cessation of the drug therapy. Serum ferritin levels fell in 24 of 32 patients (75%) who received deferasirox for over 1 year from a mean (SD) 6323·37 (2756·5) μg/L to 5458·91 (2301·2) μg/L (p<0·05).

Conclusions: Therapy with deferasirox is safe in paediatric patients with thalassaemia major. However, they should be carefully monitored for side-effects.

背景:铁螯合治疗是重度地中海贫血患者输血依赖治疗的重要组成部分。去铁宁是一种相对较新的口服铁螯合剂,其在儿童中的使用经验有限。目的:报告北印度β-地中海贫血儿童去铁铁治疗的经验。方法:本前瞻性研究纳入40例输血依赖性β-地中海贫血患者。在开始去铁铁治疗前,患者分别单独接受去铁酮治疗(37例)或去铁酮与去铁胺联合治疗(3例)。每月对患者进行临床监测。从患者记录中获得了有关副作用的信息,包括胃肠道症状、皮疹或皮肤变色、黄疸以及视力和听力方面的主诉。实验室调查包括全血细胞计数和肾功能和肝功能测试,在基线估计,然后每个月。在基线时测定血清铁蛋白水平,然后每3个月测定一次。去铁铁铁的初始剂量为20 mg/kg/体重,如果在去铁铁铁铁治疗后3个月血清铁蛋白保持不变或升高,则增加至25 mg/kg。结果:40例患儿对去铁素治疗耐受良好。胃肠道症状是最常见的副作用。恶心、呕吐和腹痛分别占25%、20%和15%。5%的病例出现皮疹。我们观察到四个(10%)儿童的皮肤有灰褐色色素沉着,这是以前没有描述过的。16例(40%)患者血清肌酐呈非进行性升高。然而,在大多数情况下,血清肌酐保持在正常范围内。未见白细胞减少、中性粒细胞减少和血小板减少。这些副作用都不需要停止药物治疗。32例患者中有24例(75%)接受去铁铁肽治疗超过1年,血清铁蛋白水平从平均(SD) 6323.37 (2756.5) μg/L降至5458·91(2301·2)μg/L(结论:去铁肽治疗小儿重度地中海贫血是安全的。然而,应该仔细监测它们的副作用。
{"title":"Safety and efficacy of deferasirox in multitransfused Indian children with β-thalassaemia major.","authors":"J Chandra,&nbsp;H Chaudhary,&nbsp;H Pemde,&nbsp;V Singh,&nbsp;A K Dutta","doi":"10.1179/1465328110Y.0000000002","DOIUrl":"https://doi.org/10.1179/1465328110Y.0000000002","url":null,"abstract":"<p><strong>Background: </strong>Iron chelation is an important component of management of transfusion-dependent patients with thalassaemia major. Deferasirox is a relatively new oral iron chelator and experience of its use in children is limited.</p><p><strong>Aim: </strong>To report experience with deferasirox in north Indian children with β-thalassaemia major.</p><p><strong>Methods: </strong>This prospective study included 40 patients with transfusion-dependent β-thalassaemia major. The patients were receiving deferiprone alone (37 patients) or deferiprone and desferrioxamine combination (three patients) before commencing deferasirox. Patients were clinically monitored every month. Information on side-effects including gastro-intestinal symptoms, skin rash or discoloration, jaundice and complaints regarding vision and hearing were obtained from patient records. Laboratory investigations included complete blood count and renal and liver function tests estimated at baseline and then every month. Serum ferritin level was estimated at baseline and then every 3 months. The initial dose of deferasirox was 20 mg/kg/body weight and was increased to 25 mg/kg if serum ferritin remained unchanged or increased 3 months after deferasirox therapy.</p><p><strong>Results: </strong>Therapy with deferasirox in 40 children was well tolerated. Gastro-intestinal symptoms were the most common side-effects. Nausea, vomiting and abdominal pain were observed in 25%, 20% and 15% patients, respectively. Skin rashes were seen in 5% cases. We observed greyish-brown pigmentation of the skin in four (10%) children which has not been described before. A non-progressive rise in serum creatinine was observed in 16 (40%) patients. In the majority, however, serum creatinine remained within the normal range. Leucopenia, neutropenia and thrombocytopenia were not observed. None of the side-effects necessitated cessation of the drug therapy. Serum ferritin levels fell in 24 of 32 patients (75%) who received deferasirox for over 1 year from a mean (SD) 6323·37 (2756·5) μg/L to 5458·91 (2301·2) μg/L (p<0·05).</p><p><strong>Conclusions: </strong>Therapy with deferasirox is safe in paediatric patients with thalassaemia major. However, they should be carefully monitored for side-effects.</p>","PeriodicalId":50759,"journal":{"name":"Annals of Tropical Paediatrics","volume":"31 1","pages":"47-51"},"PeriodicalIF":0.0,"publicationDate":"2011-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1179/1465328110Y.0000000002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29622403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 12
期刊
Annals of Tropical Paediatrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1